Compare Deutsche Bank AG (DB) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Quest Diagnostics Inc — how do they compare? Deutsche Bank AG trades at $38.21 (market cap $71.96B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Deutsche Bank AG is far larger — about 2.7× Quest Diagnostics Inc's market cap, and Deutsche Bank AG pays the higher dividend (3.04%). Which is the better fit depends on your goals.
| DB | DGX | |
|---|---|---|
Market Cap | $71.96B | $26.21B |
Sector | Financials | Health |
52-Week High | $40.33 | $238.50 |
52-Week Low | $28.37 | $173.49 |
Dividend Yield | 3.04% | 1.45% |
Enterprise Value | — | $31.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
